[Comment] Scaling up clinical research capacity in Africa requires more non-communicable disease studies

There is a growing opportunity to expand clinical research capacity in Africa, and numerous organisations are contributing to this effort. To name a few: the African Medicines Agency provides leadership for creating an enabling regulatory environment for pharmaceutical sector development in Africa;1 WHO's Clinical Trials Forum calls for an “always on, always busy, always ready” approach to clinical trials;2 and the Africa Centres for Disease Control and Prevention have developed a roadmap for optimising efficiency and impact in the African clinical trials ecosystem.